Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo. (Q52831377)
Jump to navigation
Jump to search
scientific article published in October 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo. |
scientific article published in October 2007 |
Statements
Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo. (English)
Gergely P Vasvari
Gerhard Dyckhoff
Farzaneh Kashfi
Britt Lemke
Jennifer Lohr
Burkhard M Helmke
Volker Schirrmacher
Peter K Plinkert
Philipp Beckhove
Christel C Herold-Mende
1 October 2007
121
8
1697-1704
1 reference
1 reference